Understanding PHH’s financial ratios: A beginner’s guide

Preston Campbell

Park Ha Biological Technology Co Ltd (PHH)’s stock is trading at $0.48 at the moment marking a fall of -0.29% from the last session close. As of this writing, shares are priced at -98.85% less than their 52-week high of $41.49, and 15.96% over their 52-week low of $0.41. Based on the past 30-day period, the stock price is -14.21% below the high and +16.89% above the low.

Further, it is important to consider PHH stock ratios, particularly its price-to-sales ratio over the past twelve months, which stands at 5.05.Likewise, its price to free cash flow for the last twelve months stands at 12.84. PHH’s price to book ratio for the most recent quarter was 3.29, resulting in an 10.37 price to cash per share for the period.

How does Park Ha Biological Technology Co Ltd (PHH) stock rate among analysts? Buy, sell, or hold?

The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 0 brokerage firms that recommend the stock as a Strong Sell. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 0.00 in simple terms.

Park Ha Biological Technology Co Ltd (NASDAQ: PHH) Ownership Details

I will give a breakdown of the key shareholders in Park Ha Biological Technology Co Ltd (PHH). Recent figures show that the company’s insiders hold 63.62% of shares. A total of 14 institutional investors hold shares in the company, making 0.34% of its stock and 0.93% of its float.

Aug 31, 2025, it was reported that the Company’s largest institutional holder is Invesco Exchange-Traded Fund Trust-Invesco Golden Dragon China ETF holding total of 20.27 shares that make 0.06% of the company’s total number of shares and are currently priced at 9729.0.

The securities firm Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund holds 16.85 shares of PHH, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 0.05%, and the holding percentage of shares is valued at 8089.0.

An overview of Park Ha Biological Technology Co Ltd’s technicals

In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Park Ha Biological Technology Co Ltd (PHH) traded 791,484 shares per day, with a moving average of $0.4766 and price change of -0.0026. With the moving average of $0.5743 and a price change of -0.4003, about 808,250 shares changed hands on average over the past 50 days. Finally, PHH’s 100-day average volume is 1,274,936 shares, alongside a moving average of $8.7562 and a price change of -14.0446.

US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.